Navigation Links
The probability of surviving nine types of cancer is analyzed
Date:7/15/2010

"The innovative factor contributed by our work is its relevance to population and measurement of relative survival, which enables us to discover survival related to cancer in a more precise way", Mara Dolores Chirlaque, main author of the study and researcher in the Epidemiology Service of the Department of Health and Consumption in Murcia, explains to SINC.

The investigation, which has been published in the journal Annals of Oncology, involved the participation of eight Spanish regions which currently hold a population record of cancer (Basque Country, Navarra, Girona, Tarragona, Castelln, Albacete, Murcia and Granada). It shows all the cases of cancer diagnosed between 1995 and 1999 (57,622), their monitoring until December 2004, and their prognosis.

The results enable us to understand the situation and survival five years after the diagnosis of eight malignant tumours in Spain (breast, lung, colon, rectum, prostate, ovary, testicle, melanoma and Hodgkin's lymphoma).

"When compared to the survival average in Europe, Spain is very close to the European average for the nine tumours studied, with differences less than 2%", highlights the researcher. The highest survival rate for most of the tumours is observed in Finland, Sweden, Norway and Iceland. On the other hand, the lowest corresponds to the Czech Republic, Poland and Slovenia.

As for Spain, the greatest differences have been detected in lung cancer (12.4% in Navarra as opposed to 6.1% in Granada), and the smallest, in breast cancer (91.3% in Castelln versus 81.2% in Albacete). [*More information in the table attached].

Survival percentages

"In the past cancer was considered to be fatal. However, nowadays it has come to be recognised as a curable illness", Chirlaque points out. "Testimony to this is the results shown in this study, which indicate that of every four people who suffer from it (with the exception of lung cancer), more than three overcome it".

  1. Breast cancer, the most common tumour in women, presents a high survival percentage: 83% of patients have survived this type of cancer after five years.

  2. Lung cancer is one of the most aggressive tumours and survival after five years is very low: only 10% of patients diagnosed with a malignant neoplasm survive for more than five years.

  3. Colorectal cancer (of the colon and rectum), the most common malignant tumour if we group men and women together, presents an average survival rate of 50-55% five years after diagnosis, meaning that half the patients survive this form of cancer.

  4. Prostate cancer, today the most common tumour in men, has an increasingly favourable prognosis, with a global survival rate of 76%, which is higher in young adults.

  5. Ovarian cancer presents a very varied prognosis depending on age: whilst 70% of the group between 15 and 44 years survives this form of cancer, this is the case for only 19% of those over 74 years-old.

  6. Testicular cancer, a rare malignant tumour that mainly affects middle-aged males, is the tumour with the best prognosis, with a 95% survival rate five years after diagnosis.

  7. Skin melanoma displays one of the highest survival rates, reaching values over 85%, although there are European countries where recovery exceeds 90%.

  8. Hodgkin's lymphoma displays high recovery with survival greater than 92% amongst young people, although amongst elderly groups it fails to reach 50%.


'/>"/>

Contact: SINC
info@plataformasinc.es
34-914-251-820
FECYT - Spanish Foundation for Science and Technology
Source:Eurekalert  

Related medicine news :

1. Social Security Disability Benefits Can Be Crucial to Surviving With Spinal Cord Injury, Allsup Reports
2. Surviving Cardiac Arrest Depends on Your Location
3. Chances of surviving cardiac arrest depends on your neighborhood
4. The Practical Visionary Offers Eight Keys to Surviving and Thriving in the 21st Century
5. Behavior problems in school linked to 2 types of families
6. Friendships, family relationships get better with age thanks to forgiveness, stereotypes
7. Easy Lawsuit Funding Now Offers Lawsuit Loan on All Types of Employment Lawsuits
8. Effort to Cure Some Types of Hearing Loss Gets Big Boost
9. Simple Test May Identify Breast Cancer Subtypes
10. Simple gene test identifies clinically important subtypes of breast cancer
11. Matching Tumor Types to Drugs Boosts Lung Cancer Outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
The probability of surviving nine types of cancer is analyzed
(Date:2/13/2016)... (PRWEB) , ... February 13, 2016 , ... In the ... forward. They’ll groom themselves to perfection, go out of their way to be romantic, ... – just take a look at any online dating profile. , A recent ...
(Date:2/12/2016)... , ... February 12, 2016 , ... According to an ... are beginning to account for a significant portion of hernia repairs throughout the United ... the Beverly Hills Hernia Center notes that this trend has not only been expected, ...
(Date:2/12/2016)... ... February 12, 2016 , ... The law firm of Morrow, Morrow, Ryan & ... purpose of these scholarships is to encourage applicants to pursue a degree in their ... these two parishes. , “We have available jobs in St. Landry and Evangeline ...
(Date:2/12/2016)... ... February 12, 2016 , ... The Lymphoma ... innovative lymphoma research and serving the lymphoma community through a comprehensive series of ... South Florida’s philanthropic community at its 10th anniversary Fashion Luncheon on Monday, February ...
(Date:2/12/2016)... ... 12, 2016 , ... Fixed Dose Combination Drug Development: , ... http://www.fdanews.com/fixeddosecombination , Fixed dose combination products are a ... from all stakeholders in the development of new chemical entities. , However, the ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... and Company (NYSE: LLY ) today announced that the ... patent would not presently be infringed by Actavis marketing pemetrexed ... Italy and Spain ... --> --> In ... Lilly,s patent would be indirectly infringed by Actavis marketing certain ...
(Date:2/12/2016)... North Carolina , 12 februari 2016 ... Inc. (AAI/CML), een toonaangevende leverancier van productie ... en biotechnologische industrieën, kondigt vandaag een uitbreiding ... mogelijkheden op haar locatie in ... vraag heeft geleid tot meerdere recente investeringen. ...
(Date:2/12/2016)... --> ... Global Clinical Trials Review, H2, 2015 provides an ... trials landscape along with top level data related ... & E7), Trial Status, Trial Phase, Sponsor Type ... involved and enlists all trials (Trial title, Phase, ...
Breaking Medicine Technology: